Imamoto T - Search Results

1

Association between serum sex hormone levels and prostate cancer: effect of prostate cancer on serum testosterone levels.

Imamoto T, Suzuki H, Utsumi T, Endo T, Takano M, Yano M, Kawamura K, Kamiya N, Nihei N, Naya Y, Ichikawa T. Imamoto T, et al. Future Oncol. 2009 Sep;5(7):1005-13. doi: 10.2217/fon.09.82. Future Oncol. 2009. PMID: 19792969 Review.

2

Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy.

Imamoto T, Suzuki H, Fukasawa S, Shimbo M, Inahara M, Komiya A, Ueda T, Shiraishi T, Ichikawa T. Imamoto T, et al. Eur Urol. 2005 Mar;47(3):308-12. doi: 10.1016/j.eururo.2004.11.003. Epub 2004 Dec 29. Eur Urol. 2005. PMID: 15716191 Clinical Trial.

3

CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.

Shimbo M, Suzuki H, Kamiya N, Imamoto T, Komiya A, Ueda T, Watanabe M, Shiraishi T, Ichikawa T. Shimbo M, et al. Among authors: imamoto t. Eur Urol. 2005 Apr;47(4):557-63. doi: 10.1016/j.eururo.2004.10.016. Epub 2004 Dec 16. Eur Urol. 2005. PMID: 15774258

4

Clinical significance of urinary white blood cell count and serum C-reactive protein level for detection of non-palpable prostate cancer.

Kato T, Suzuki H, Komiya A, Imamoto T, Naya Y, Tobe T, Ichikawa T. Kato T, et al. Among authors: imamoto t. Int J Urol. 2006 Jul;13(7):915-9. doi: 10.1111/j.1442-2042.2006.01440.x. Int J Urol. 2006. PMID: 16882055

5

The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening.

Yano M, Imamoto T, Suzuki H, Fukasawa S, Kojima S, Komiya A, Naya Y, Ichikawa T. Yano M, et al. Among authors: imamoto t. Eur Urol. 2007 Feb;51(2):375-80. doi: 10.1016/j.eururo.2006.08.047. Epub 2006 Sep 12. Eur Urol. 2007. PMID: 17005316

6

[Synthesized androgens].

Suzuki H, Imamoto T, Ichikawa T. Suzuki H, et al. Among authors: imamoto t. Nihon Rinsho. 2008 Jan;66(1):99-103. Nihon Rinsho. 2008. PMID: 18193549 Review. Japanese.

7

[Bony lesion with prostate cancer].

Kamiya N, Suzuki H, Kawamura K, Imamoto T, Ichikawa T. Kamiya N, et al. Among authors: imamoto t. Clin Calcium. 2008 Apr;18(4):431-7. Clin Calcium. 2008. PMID: 18379023 Review. Japanese.

8

The role of testosterone in the pathogenesis of prostate cancer.

Imamoto T, Suzuki H, Yano M, Kawamura K, Kamiya N, Araki K, Komiya A, Nihei N, Naya Y, Ichikawa T. Imamoto T, et al. Int J Urol. 2008 Jun;15(6):472-80. doi: 10.1111/j.1442-2042.2008.02074.x. Epub 2008 Apr 22. Int J Urol. 2008. PMID: 18430151 Review.

9

Neuroendocrine differentiation in stage D2 prostate cancers.

Kamiya N, Suzuki H, Kawamura K, Imamoto T, Naya Y, Tochigi N, Kakuta Y, Yamaguchi K, Ishikura H, Ichikawa T. Kamiya N, et al. Among authors: imamoto t. Int J Urol. 2008 May;15(5):423-8. doi: 10.1111/j.1442-2042.2008.02015.x. Int J Urol. 2008. PMID: 18452460

10

Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.

Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T. Kawamura K, et al. Among authors: imamoto t. Int J Urol. 2008 Jul;15(7):598-603. doi: 10.1111/j.1442-2042.2008.02058.x. Epub 2008 May 2. Int J Urol. 2008. PMID: 18462353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page